Although further studies are needed to examine the effects of L-DOPA in uninjected mice and other PD animal models, this α-synuclein transmission model using WT mice reproduces similar lesions without the need for a nucleation process, which is the rate-limiting step of these types of abnormal protein aggregations. This evidence concerns the gene SNCA and Parkinson disease.